Literature DB >> 15271904

Production of the subdomains of the Plasmodium falciparum apical membrane antigen 1 ectodomain and analysis of the immune response.

P V Lalitha1, Lisa A Ware, Arnoldo Barbosa, Sheetij Dutta, J Kathleen Moch, J David Haynes, Bader B Fileta, Charles E White, David E Lanar.   

Abstract

The apical membrane antigen 1 of Plasmodium falciparum is one of the leading candidate antigens being developed as a vaccine to prevent malaria. This merozoite transmembrane protein has an ectodomain that can be divided into three subdomains (D I, D II, and D III). We have previously expressed a major portion of this ectodomain and have shown that it can induce antibodies that prevent merozoite invasion into red blood cells in an in vitro growth and invasion assay. To analyze the antibody responses directed against the individual subdomains, we constructed six different genes that express each of the domains separately (D I, D II, or D III) or in combination with another domain (D I+II, D II+III, or D I+III). These proteins were purified and used to immunize rabbits to raise construct-specific antibodies. We demonstrated that D I+II induced a significant amount of the growth-inhibitory antibodies active in the growth and invasion assay.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15271904      PMCID: PMC470679          DOI: 10.1128/IAI.72.8.4464-4470.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Strong diversifying selection on domains of the Plasmodium falciparum apical membrane antigen 1 gene.

Authors:  S D Polley; D J Conway
Journal:  Genetics       Date:  2001-08       Impact factor: 4.562

2.  Proteolytic processing and primary structure of Plasmodium falciparum apical membrane antigen-1.

Authors:  S A Howell; C Withers-Martinez; C H Kocken; A W Thomas; M J Blackman
Journal:  J Biol Chem       Date:  2001-06-08       Impact factor: 5.157

3.  Diversity of the vaccine candidate AMA-1 of Plasmodium falciparum.

Authors:  V M Marshall; L Zhang; R F Anders; R L Coppel
Journal:  Mol Biochem Parasitol       Date:  1996-04       Impact factor: 1.759

4.  Polymorphism in the gene encoding the apical membrane antigen-1 (AMA-1) of Plasmodium falciparum. X. Asembo Bay Cohort Project.

Authors:  A A Escalante; H M Grebert; S C Chaiyaroj; M Magris; S Biswas; B L Nahlen; A A Lal
Journal:  Mol Biochem Parasitol       Date:  2001-04-06       Impact factor: 1.759

5.  Specificity of the protective antibody response to apical membrane antigen 1.

Authors:  A N Hodder; P E Crewther; R F Anders
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

6.  Antibodies reactive with the N-terminal domain of Plasmodium falciparum serine repeat antigen inhibit cell proliferation by agglutinating merozoites and schizonts.

Authors:  X L Pang; T Mitamura; T Horii
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

7.  Apical membrane antigen 1 plays a central role in erythrocyte invasion by Plasmodium species.

Authors:  T Triglia; J Healer; S R Caruana; A N Hodder; R F Anders; B S Crabb; A F Cowman
Journal:  Mol Microbiol       Date:  2000-11       Impact factor: 3.501

8.  Purification, characterization, and immunogenicity of the refolded ectodomain of the Plasmodium falciparum apical membrane antigen 1 expressed in Escherichia coli.

Authors:  Sheetij Dutta; P V Lalitha; Lisa A Ware; Arnoldo Barbosa; J Kathleen Moch; Meredith A Vassell; Bader B Fileta; Svetlana Kitov; Nelly Kolodny; D Gray Heppner; J David Haynes; David E Lanar
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

9.  High-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion.

Authors:  Clemens H M Kocken; Chrislaine Withers-Martinez; Martin A Dubbeld; Annemarie van der Wel; Fiona Hackett; Augusto Valderrama; Michael J Blackman; Alan W Thomas
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

10.  Immunization with parasite-derived apical membrane antigen 1 or passive immunization with a specific monoclonal antibody protects BALB/c mice against lethal Plasmodium yoelii yoelii YM blood-stage infection.

Authors:  D L Narum; S A Ogun; A W Thomas; A A Holder
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

View more
  11 in total

1.  Allele specificity of naturally acquired antibody responses against Plasmodium falciparum apical membrane antigen 1.

Authors:  Alfred Cortés; Mata Mellombo; Rosella Masciantonio; Vince J Murphy; John C Reeder; Robin F Anders
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

2.  Mode of action of invasion-inhibitory antibodies directed against apical membrane antigen 1 of Plasmodium falciparum.

Authors:  Sheetij Dutta; J David Haynes; Arnoldo Barbosa; Lisa A Ware; Jeffrey D Snavely; J Kathleen Moch; Alan W Thomas; David E Lanar
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

3.  Structural basis of antigenic escape of a malaria vaccine candidate.

Authors:  Sheetij Dutta; Seung Yeon Lee; Adrian H Batchelor; David E Lanar
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-16       Impact factor: 11.205

4.  Allelic diversity and naturally acquired allele-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 in Kenya.

Authors:  Faith H A Osier; Gareth D Weedall; Federica Verra; Linda Murungi; Kevin K A Tetteh; Pete Bull; Bart W Faber; Ed Remarque; Alan Thomas; Kevin Marsh; David J Conway
Journal:  Infect Immun       Date:  2010-08-23       Impact factor: 3.441

5.  Functional analysis of Plasmodium falciparum apical membrane antigen 1 utilizing interspecies domains.

Authors:  Julie Healer; Tony Triglia; Anthony N Hodder; Alan W Gemmill; Alan F Cowman
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

6.  Malaria vaccine-related benefits of a single protein comprising Plasmodium falciparum apical membrane antigen 1 domains I and II fused to a modified form of the 19-kilodalton C-terminal fragment of merozoite surface protein 1.

Authors:  Bart W Faber; Edmond J Remarque; William D Morgan; Clemens H M Kocken; Anthony A Holder; Alan W Thomas
Journal:  Infect Immun       Date:  2007-10-15       Impact factor: 3.441

7.  Vaccination with Plasmodium knowlesi AMA1 formulated in the novel adjuvant co-vaccine HT™ protects against blood-stage challenge in rhesus macaques.

Authors:  Muzamil Mahdi Abdel Hamid; Edmond J Remarque; Leonie M van Duivenvoorde; Nicole van der Werff; Vanessa Walraven; Bart W Faber; Clemens H M Kocken; Alan W Thomas
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

8.  Identification of a highly antigenic linear B cell epitope within Plasmodium vivax apical membrane antigen 1 (AMA-1).

Authors:  Lilian Lacerda Bueno; Francisco Pereira Lobo; Cristiane Guimarães Morais; Luíza Carvalho Mourão; Ricardo Andrez Machado de Ávila; Irene Silva Soares; Cor Jesus Fontes; Marcus Vinícius Lacerda; Carlos Chavez Olórtegui; Daniella Castanheira Bartholomeu; Ricardo Toshio Fujiwara; Erika Martins Braga
Journal:  PLoS One       Date:  2011-06-21       Impact factor: 3.240

9.  Humoral immune responses to a single allele PfAMA1 vaccine in healthy malaria-naïve adults.

Authors:  Edmond J Remarque; Meta Roestenberg; Sumera Younis; Vanessa Walraven; Nicole van der Werff; Bart W Faber; Odile Leroy; Robert Sauerwein; Clemens H M Kocken; Alan W Thomas
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

10.  Overcoming antigenic diversity by enhancing the immunogenicity of conserved epitopes on the malaria vaccine candidate apical membrane antigen-1.

Authors:  Sheetij Dutta; Lisa S Dlugosz; Damien R Drew; Xiaopeng Ge; Xiopeng Ge; Diouf Ababacar; Yazmin I Rovira; J Kathleen Moch; Meng Shi; Carole A Long; Michael Foley; James G Beeson; Robin F Anders; Kazutoyo Miura; J David Haynes; Adrian H Batchelor
Journal:  PLoS Pathog       Date:  2013-12-26       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.